RUA Life Sciences (GB:RUA)
LSE:RUA
Total Valuation
RUA Life Sciences has a market cap or net worth of £8.38M. The enterprise value is 6.48M .
Market Cap£8.38M
Enterprise Value6.48M
Share Statistics
RUA Life Sciences has 62,060,272 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding62,060,272
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
RUA Life Sciences’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -9.97%.
Return on Equity (ROE)-0.02
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-9.97%
Return on Capital Employed (ROCE)-0.10
Revenue Per Employee111.48K
Profits Per Employee-3.63K
Employee Count40
Asset Turnover0.49
Inventory Turnover1.57
Valuation Ratios
The current PE Ratio of RUA Life Sciences is 3.6. RUA Life Sciences’s PEG ratio is 0.00.
PE Ratio3.6
PS Ratio1.57
PB Ratio0.98
Price to Fair Value0.98
Price to FCF-23.43
Price to Operating Cash Flow-61.15
PEG Ratio0.00
Income Statement
In the last 12 months, RUA Life Sciences had revenue of 4.46M and earned -145.33K in profits. Earnings per share was >-0.01.
Revenue4.46M
Gross Profit3.06M
Operating Income-826.67K
Pretax Income-157.33K
Net Income-145.33K
EBITDA-383.33K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -162.00K and capital expenditures -161.00K, giving a free cash flow of -323.00K billion.
Operating Cash Flow-162.00K
Free Cash Flow-323.00K
Free Cash Flow per Share>-0.01
Dividends & Yields
RUA Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.28
52-Week Price Change20.00%
50-Day Moving Average13.73
200-Day Moving Average12.51
Relative Strength Index (RSI)54.60
Average Volume (3m)148.53K
Important Dates
RUA Life Sciences upcoming earnings date is Jul 13, 2026, TBA (Confirmed).
Last Earnings DateJan 30, 2026
Next Earnings DateJul 13, 2026
Ex-Dividend Date―
Financial Position
RUA Life Sciences as a current ratio of 4.64, with Debt / Equity ratio of 18.95%
Current Ratio4.64
Quick Ratio3.87
Debt to Market Cap0.03
Net Debt to EBITDA6.41
Interest Coverage Ratio0.00
Taxes
In the past 12 months, RUA Life Sciences has paid -2.00K in taxes.
Income Tax-2.00K
Effective Tax Rate0.01
Enterprise Valuation
RUA Life Sciences EV to EBITDA ratio is -11.81, with an EV/FCF ratio of -15.19.
EV to Sales1.01
EV to EBITDA-11.81
EV to Free Cash Flow-15.19
EV to Operating Cash Flow-33.03
Balance Sheet
RUA Life Sciences has £3.25M in cash and marketable securities with £1.35M in debt, giving a net cash position of £1.90M billion.
Cash & Marketable Securities£3.25M
Total Debt£1.35M
Net Cash£1.90M
Net Cash Per Share£0.03
Tangible Book Value Per Share£0.11
Margins
Gross margin is 68.56%, with operating margin of -18.54%, and net profit margin of -3.26%.
Gross Margin68.56%
Operating Margin-18.54%
Pretax Margin-3.53%
Net Profit Margin-3.26%
EBITDA Margin-8.60%
EBIT Margin-18.54%
Analyst Forecast
The average price target for RUA Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast87.72%
EPS Growth Forecast―